![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Grupo Aval Acciones y Valores SA | NYSE:AVAL | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.0001 | 0.00% | 2.1701 | 2.18 | 2.15 | 2.18 | 43,416 | 20:14:34 |
Regulatory News:
VALBIOTIS (Paris:AVAL) (FR0013254851 - ALVAL / PEA/SME eligible), a company that specializes in developing innovative nutrition solutions designed to prevent cardiometabolic diseases and provide nutritional support for patients, today presents its financial communication calendar for 2018:
In order to strengthen its relationships with its shareholders, VALBIOTIS has decided to start editing and circulating a “Letter to the shareholders”, on a regular basis. The first issue was printed and sent by mail in February 2018.
A corporate presentation has also been updated in February 2018.
Both digital documents are available on the company website, at the following link: http://VALBIOTIS.com/en/documentation/
ABOUT VALBIOTIS
VALBIOTIS specializes in developing innovative nutrition solutions designed to prevent cardiometabolic diseases and provide nutritional support for patients. Its products are made for manufacturers in the agri-food and pharmaceutical industries. VALBIOTIS particularly focuses on solutions to prevent type 2 diabetes, NASH (nonalcoholic steatohepatitis), obesity and cardiovascular diseases.
VALBIOTIS was founded in La Rochelle in early 2014 and has formed numerous partnerships with top academic centers in France and abroad, including the La Rochelle University, the CNRS and the Clermont Auvergne University located in Clermont-Ferrand, where the company opened a second office. These agreements enable it to benefit from a considerable leverage effect since it was set up thanks, in particular, to the experts and technical partners mobilized for these projects. VALBIOTIS is a member of the “BPI Excellence” network and received the “Innovative Company” status accorded by BPI France. VALBIOTIS has also been awarded “Young Innovative Company” status and has received major financial support from the European Union for its research programs by obtaining support from the European Regional Development Fund (ERDF).
Find out more about VALBIOTIS:http://VALBIOTIS.com/
Name: VALBIOTISISIN code: FR0013254851Mnemonic Code: ALVAL
View source version on businesswire.com: http://www.businesswire.com/news/home/20180223005174/en/
FINANCIAL COMMUNICATIONACTIFINStéphane Ruiz, +33 1 56 88 11 14sruiz@actifin.frorPRESS RELATIONSALIZE PRCaroline Carmagnol / Wendy Rigal+33 1 44 54 36 66VALBIOTIS@alizerp.comorCOMMUNICATIONS DEPARTMENTVALBIOTISMarc Delaunay, +33 5 46 28 62 58marc.delaunay@VALBIOTIS.com
1 Year Grupo Aval Acciones y Va... Chart |
1 Month Grupo Aval Acciones y Va... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions